Jounce Therpeutc Common Stock
10.98
26-February-21 15:59:59
15 minutes delayed
Stocks
-0.78
-6.63%
Today's range
10.87 - 12.15
ISIN
N/A
Source
NASDAQ
-
Jounce Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results
25 Feb 2021 06:30:00 By Nasdaq GlobeNewswire
-
Jounce Therapeutics to Present at Upcoming Investor Conferences in March
23 Feb 2021 08:00:01 By Nasdaq GlobeNewswire
-
18 Feb 2021 08:00:01 By Nasdaq GlobeNewswire
-
Jounce Therapeutics Appoints Luisa Salter-Cid, Ph.D., to its Board of Directors
12 Feb 2021 08:00:00 By Nasdaq GlobeNewswire
-
Jounce Therapeutics to Present at Upcoming Investor Conferences in January
08 Jan 2021 08:00:00 By Nasdaq GlobeNewswire
-
Jounce Therapeutics Added to NASDAQ Biotechnology Index
16 Dec 2020 08:00:01 By Nasdaq GlobeNewswire
-
25 Nov 2020 08:00:00 By Nasdaq GlobeNewswire
-
16 Nov 2020 08:00:01 By Nasdaq GlobeNewswire
-
11 Nov 2020 08:00:00 By Nasdaq GlobeNewswire
-
Jounce Therapeutics to Participate in a Virtual Fireside Chat at Cowen 2020 IO Next Summit
09 Nov 2020 08:00:01 By Nasdaq GlobeNewswire
-
Jounce Therapeutics Reports Third Quarter 2020 Financial Results
06 Nov 2020 07:00:00 By Nasdaq GlobeNewswire
-
Jounce Therapeutics Announces Update on Vopratelimab Program
02 Nov 2020 07:00:01 By Nasdaq GlobeNewswire
-
30 Oct 2020 08:00:10 By Nasdaq GlobeNewswire
-
Jounce Therapeutics to Participate in Upcoming Virtual Investor Conferences in September
02 Sep 2020 16:01:10 By Nasdaq GlobeNewswire
-
01 Sep 2020 08:30:10 By Nasdaq GlobeNewswire
-
Jounce Therapeutics Reports Second Quarter 2020 Financial Results
07 Aug 2020 06:30:10 By Nasdaq GlobeNewswire
-
Jounce Therapeutics to Participate in a Fireside Chat at BTIG Virtual Biotechnology Conference 2020
04 Aug 2020 08:00:11 By Nasdaq GlobeNewswire
-
31 Jul 2020 08:00:10 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >